Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal model

Mao,Shanhua; Xu,Hua; Zou,Lujia; Xu,Gang; Wu,Zhong; Ding,Qiang; Jiang,Haowen

doi:10.3892/etm.2014.1663

Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal model

Authors:
- Shanhua Mao
- Hua Xu
- Lujia Zou
- Gang Xu
- Zhong Wu
- Qiang Ding
- Haowen Jiang
View Affiliations

Affiliations: Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
Published online on: April 3, 2014 https://doi.org/10.3892/etm.2014.1663
Pages: 1555-1562

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Estrogen may help to preserve renal function in chronic kidney disease. This study examined whether estrogen administration or deprivation affected the split renal function in rats subjected to chronic unilateral ureteral obstruction (UUO). Fifteen adult female Sprague‑Dawley rats were randomly divided into three groups. Low- and high‑estrogen groups were modeled by female castration or estrogen intraperitoneal injection, respectively, and the rats in the normal-estrogen group were untreated. Intermittent split renal function [glomerular filtration rate (GFR)] examination was performed on rats on days 2, 6 and 16 after UUO surgery via single‑photon emission computed tomography (SPECT/CT). Routine hematoxylin and eosin (H&E) staining, immunohistochemistry, pathology examination and electron microscopy were performed to compare the histological differences. Low-, normal- and high-estrogen groups were successfully established (P<0.001). In the acute stage, the GFR of the contralateral healthy kidney showed a greater compensatory rise in the normal- and high-estrogen groups than in the low‑estrogen group (P<0.05). In the chronic stage, the GFR of the obstructed kidney continued to decrease with the GFR of the high-estrogen group being significantly better preserved than that of the low-estrogen group (P<0.05). The GFR of the contralateral kidney compensated to the greatest extent in the high-estrogen group (P=0.01), and the total GFR was significantly superior (P<0.05). Routine H&E examination showed significant histological changes following surgery. The low-estrogen group had significant renal interstitial fibrosis compared with the normal- and high‑estrogen groups (P<0.05), as observed by immunohistochemical (IHC) examination of transforming growth factor-β (TGF-β) and α-smooth muscle actin (α-SMA). Electron‑microscopic (EM) examination also differentiated between groups. In conclusion, estrogen administration and deprivation significantly affected renal function. Estrogen may preserve the split renal function (GFR) in rats with chronic UUO.

View Figures

View References

1	Yasui T, Iguchi M, Suzuki S and Kohri K: Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 71:209–213. 2008. View Article : Google Scholar : PubMed/NCBI
2	Takahashi T, Yamane A, Okasho K, et al: Incidence of upper urinary tract stone during 15 years in Tajima area, Japan: a hospital-based study. Urol Res. 37:305–310. 2009.PubMed/NCBI
3	Tanagho EA: Urinary obstruction & stasis. Smith’s General Urology. Tanagho EA and McAninch JW: 17th edition. McGraw-Hill; New York: pp. 1662008
4	Mao S, Jiang H, Wu Z, et al: Urolithiasis: the most risk for nephrectomy in nonrenal tumor patients. J Endourol. 26:1356–1360. 2012. View Article : Google Scholar : PubMed/NCBI
5	Ji H, Menini S, Mok K, et al: Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol. 288:F513–F520. 2005. View Article : Google Scholar : PubMed/NCBI
6	Fung MM, Poddar S, Bettencourt R, et al: A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study. Menopause. 18:629–637. 2011.PubMed/NCBI
7	Cherikh WS, Young CJ, Kramer BF, et al: Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant. 11:1650–1655. 2011. View Article : Google Scholar : PubMed/NCBI
8	Topcu SO, Pedersen M, Nørregaard R, et al: Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. Am J Physiol Renal Physiol. 292:F736–F748. 2007. View Article : Google Scholar : PubMed/NCBI
9	Baiardi G, Macova M, Armando I, et al: Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept. 124:7–17. 2005. View Article : Google Scholar : PubMed/NCBI
10	Armando I, Jezova M, Juorio AV, et al: Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol. 283:F934–F943. 2002.PubMed/NCBI
11	Thompson J and Khalil RA: Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol. 30:1–15. 2003. View Article : Google Scholar : PubMed/NCBI
12	Sandberg K: Mechanisms underlying sex differences in progressive renal disease. Gend Med. 5:10–23. 2008. View Article : Google Scholar
13	Li C, Shi Y, Wang W, et al: alpha-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction. Am J Physiol Renal Physiol. 290:F384–F396. 2006. View Article : Google Scholar : PubMed/NCBI
14	Efrati S, Berman S, Chachashvili A, et al: Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction. Nephrology (Carlton). 14:189–197. 2009. View Article : Google Scholar : PubMed/NCBI
15	Alvarez A, Hermenegildo C, Issekutz AC, et al: Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation. Circ Res. 91:1142–1150. 2002. View Article : Google Scholar
16	Rodríguez E, López R, Paez A, et al: 17Beta-estradiol inhibits the adhesion of leukocytes in TNF-alpha stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci. 71:2181–2193. 2002.PubMed/NCBI
17	Mori M, Tsukahara F, Yoshioka T, et al: Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sci. 75:599–609. 2004. View Article : Google Scholar : PubMed/NCBI
18	Silbiger SR: Raging hormones: gender and renal disease. Kidney Int. 79:382–384. 2011. View Article : Google Scholar : PubMed/NCBI
19	Kang DH, Yu ES, Yoon KI and Johnson R: The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol. 164:679–688. 2004. View Article : Google Scholar
20	Negulescu O, Bognar I, Lei J, et al: Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney Int. 62:1989–1998. 2002. View Article : Google Scholar : PubMed/NCBI
21	Ito K, Chen J, El Chaar M, et al: Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol. 287:F1283–F1293. 2004. View Article : Google Scholar : PubMed/NCBI
22	Meng XM, Chung AC and Lan HY: Role of the TGF-β/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond). 124:243–254. 2013.
23	Ina K, Kitamura H, Tatsukawa S and Fujikura Y: Significance of α-SMA in myofibroblasts emerging in renal tubulointerstitial fibrosis. Histol Histopathol. 26:855–866. 2011.
24	Heiman JR, Rupp H, Janssen E, et al: Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Horm Behav. 59:772–779. 2011. View Article : Google Scholar : PubMed/NCBI
25	Curtis KS: Estrogen and the central control of body fluid balance. Physiol Behav. 97:180–192. 2009. View Article : Google Scholar : PubMed/NCBI
26	Frøkiaer J1 and Sørensen SS: Eicosanoid excretion from the contralateral kidney in pigs with complete unilateral ureteral obstruction. J Urol. 154:1205–1209. 1995.PubMed/NCBI
27	Yarger WE, Schocken DD and Harris RH: Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest. 65:400–412. 1980. View Article : Google Scholar
28	Oelkers WK: Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids. 61:166–171. 1996. View Article : Google Scholar : PubMed/NCBI
29	Gallagher PE, Li P, Lenhart JR, Chappell MC and Brosnihan KB: Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension. 33:323–328. 1999. View Article : Google Scholar : PubMed/NCBI
30	Karl M, Berho M, Pignac-Kobinger J, et al: Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo. Am J Pathol. 169:351–361. 2006. View Article : Google Scholar : PubMed/NCBI
31	Guccione M, Silbiger S, Lei J, et al: Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol. 282:F164–F169. 2002.PubMed/NCBI
32	Zdunek M, Silbiger S, Lei J and Neugarten J: Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int. 60:2097–2108. 2001. View Article : Google Scholar : PubMed/NCBI
33	Neugarten J, Acharya A, Lei J and Silbiger S: Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol. 279:F309–F318. 2000.PubMed/NCBI
34	Studd J: ‘PROFOX’ - the post HRT nightmare. Climacteric. 14:217–219. 2011.
35	Dietel M: Hormone replacement therapy (HRT), breast cancer and tumor pathology. Maturitas. 65:183–189. 2010. View Article : Google Scholar : PubMed/NCBI
36	Brown S: IMS updates its recommendations on HRT. Menopause Int. 17:752011.PubMed/NCBI